Patrick Roth

15.0k total citations · 2 hit papers
202 papers, 7.2k citations indexed

About

Patrick Roth is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Patrick Roth has authored 202 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Genetics, 48 papers in Oncology and 45 papers in Molecular Biology. Recurrent topics in Patrick Roth's work include Glioma Diagnosis and Treatment (106 papers), Brain Metastases and Treatment (35 papers) and CNS Lymphoma Diagnosis and Treatment (22 papers). Patrick Roth is often cited by papers focused on Glioma Diagnosis and Treatment (106 papers), Brain Metastases and Treatment (35 papers) and CNS Lymphoma Diagnosis and Treatment (22 papers). Patrick Roth collaborates with scholars based in Switzerland, Germany and United States. Patrick Roth's co-authors include Michael Weller, David A. Reardon, Guido Reifenberger, Wolfgang Wick, Manuela Silginer, Caroline Happold, Matthias Preusser, Tobias Weiß, Émilie Le Rhun and Martin J. van den Bent and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Patrick Roth

192 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

2020 946 citations Patrick Roth, Juan Manuel Sepúlveda-Sánchez et al. profile →
Molecular targeted therapy of glioblastoma

2019 466 citations Émilie Le Rhun, Patrick Roth et al. profile →

Peers

Countries citing papers authored by Patrick Roth

Since Specialization

Citations

This map shows the geographic impact of Patrick Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Roth more than expected).

Fields of papers citing papers by Patrick Roth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Roth. The network helps show where Patrick Roth may publish in the future.

Co-authorship network of co-authors of Patrick Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Roth. A scholar is included among the top collaborators of Patrick Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Roth. Patrick Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma 2024 ·Acta Neuropathologica ·Michael Weller, Jörg Felsberg, Bettina Hentschel, Dorothee Gramatzki, (unknown), Marietta Wolter, (unknown), Patrick Roth, Dietmar Krex, Ulrich Herrlinger, Manfred Westphal, J. C. Tonn, Luca Regli, Claude‐Alain Maurage, Andreas von Deimling, Torsten Pietsch, Émilie Le Rhun, Guido Reifenberger	27
2	Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults 2023 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), Patrick Roth, Regina Reimann, Javad Nazarian, Ana Guerreiro Stücklin	4
3	Custom order entry for Parkinson’s medications in the hospital improves timely administration: an analysis of over 31,000 medication doses 2023 ·Frontiers in Aging Neuroscience ·Hooman Azmi, (unknown), Francis F. Ruzicka, (unknown), John M. Pederson, (unknown), (unknown), (unknown), Mary Beth Bobek, (unknown), Patrick Roth, Florian P. Thomas	1
4	RTID-03. A PHASE 1/2 STUDY OF THE WEE1 INHIBITOR DEBIO 0123 IN COMBINATION WITH TEMOZOLOMIDE +- RADIOTHERAPY IN ADULTS WITH RECURRENT OR NEWLY DIAGNOSED GLIOBLASTOMA 2023 ·Neuro-Oncology ·Patrick Roth, Kyriakos P. Papadopoulos, María Vieito, Jonathan T. Yang, Nazanin Majd, Juan Manuel Sepúlveda-Sánchez, Lauren Schaff, Víctor Moreno, (unknown), Sandrine Micallef, Anne Bellon, (unknown), (unknown), (unknown), Víctor Rodríguez-Freixinós, Jordi Rodón	1
5	Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma 2023 ·Neuro-Oncology ·(unknown), Matthias Peipp, (unknown), (unknown), Renier Myburgh, Manuela Silginer, Tobias Weiß, Dorothee Gramatzki, Flavio Vasella, Markus G. Manz, Michael Weller, Patrick Roth	9
6	Prognostic assessment in patients operated for brain metastasis from systemic tumors 2023 ·Cancer Medicine ·(unknown), (unknown), (unknown), Patrick Roth, Zsolt Kulcsár, Luca Regli, Émilie Le Rhun, Michael Weller, Fabian Wolpert	6
7	Realistic Assessment of Research Publications by Neurosurgery Residency Applicants 2023 ·World Neurosurgery ·(unknown), (unknown), (unknown), (unknown), Patrick Roth	11
8	Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older 2023 ·Neuro-Oncology Practice ·Christina Stadler, Dorothee Gramatzki, Émilie Le Rhun, Andreas F. Hottinger, Thomas Hundsberger, Ulrich Roelcke, Heinz Läubli, Silvia Höfer, Katharina Seystahl, Hans‐Georg Wirsching, Michael Weller, Patrick Roth	11
9	Venous thromboembolic events in glioblastoma patients: An epidemiological study 2022 ·European Journal of Neurology ·(unknown), Katharina Seystahl, Elisabeth J. Rushing, Patrick Roth, Émilie Le Rhun, Michael Weller, Dorothee Gramatzki	16
10	Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma 2022 ·Clinical Cancer Research ·(unknown), Thomas Look, Patrick Roth, Steve Pascolo, Uğur Şahin, Sohyon Lee, Benjamin D. Hale, Berend Snijder, Luca Regli, Vidhya M. Ravi, Dieter Henrik Heiland, Charles L. Sentman, Michael Weller, Tobias Weiß	55
11	MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial 2020 ·Clinical Cancer Research ·Hans‐Georg Wirsching, Ulrich Roelcke, Jonathan Weller, Thomas Hundsberger, Andreas F. Hottinger, Roger von Moos, Francesca Caparrotti, Katrin Conen, Luca Remonda, Patrick Roth, Adrian F. Ochsenbein, Ghazaleh Tabatabai, Michael Weller	23
12	Antidepressant drug use in glioblastoma patients: an epidemiological view 2020 ·Neuro-Oncology Practice ·Dorothee Gramatzki, James L. Rogers, Marian C. Neidert, Caroline Hertler, Émilie Le Rhun, Patrick Roth, Michael Weller	11
13	The molecular evolution of glioblastoma treated by gross total resection alone 2020 ·Neuro-Oncology ·Dorothee Gramatzki, Jörg Felsberg, Patrick Roth, Kerstin Kaulich, Andreas von Deimling, Elisabeth J. Rushing, Guido Reifenberger, Michael Weller	2
14	Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas 2019 ·Clinical Cancer Research ·(unknown), Manuela Silginer, Michael Weller, Hannah Schneider, Kathy Hasenbach, Michel Janicot, Patrick Roth	39
15	Risk factors for the development of epilepsy in patients with brain metastases 2019 ·Neuro-Oncology ·Fabian Wolpert, (unknown), Robert Terziev, (unknown), Marian C. Neidert, Patrick Roth, Rositsa Poryazova, Lukas Imbach, Émilie Le Rhun, Michael Weller	39
16	NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma 2017 ·Clinical Cancer Research ·Tobias Weiß, Hannah Schneider, Manuela Silginer, Alexander Steinle, Martin Pruschy, Bojan Polić, Michael Weller, Patrick Roth	90
17	NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma 2017 ·Cancer Research ·Tobias Weiß, Michael Weller, Matthias Gückenberger, Charles L. Sentman, Patrick Roth	231
18	Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma 2017 ·Molecular Cancer Therapeutics ·Katharina Seystahl, (unknown), Isabel Burghardt, Hannah Schneider, Kathy Hasenbach, Michel Janicot, Patrick Roth, Michael Weller	45
19	Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells 2014 ·Molecular Cancer Therapeutics ·Caroline Happold, Patrick Roth, Manuela Silginer, Ana‐Maria Florea, Katrin Lamszus, Karl Frei, René Deenen, Guido Reifenberger, Michael Weller	43
20	SC68896, a Novel Small Molecule Proteasome Inhibitor, Exerts Antiglioma Activity In vitro and In vivo 2009 ·Clinical Cancer Research ·Patrick Roth, Maria Kissel, (unknown), Günter Eisele, Johann Leban, Michael Weller, Friederike Schmidt	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact